Elizabeth Karan works on the Hemophilia Alliance’s legal team. She is an associate at Feldesman Tucker Leifer Fidell LLP in the firm’s health law and federal grants practice groups.
Elizabeth counsels a diverse array of organizations including hemophilia treatment centers, federally qualified health centers, primary care associations, and other federal grantees. Her practice focuses mainly on assisting clients with the 340B drug pricing program, grants compliance, provider collaborations, Medicaid and Medicare reimbursement issues, and implementation of the Affordable Care Act.
In her work, Elizabeth strives to ensure that her clients are meeting the obligations of the statutes and agreements that underlie their grants. Recognizing the many strings that attach to federal grants, Elizabeth assists clients with navigating these requirements. Elizabeth is well aware of the challenge to implement and remain in compliance with federal policies. She strives to make sure that despite these challenges, her clients are still able to carry out their programs and fulfill their mission.
Elizabeth’s background is in national health care policy-making. Prior to joining the firm, Elizabeth served on the U.S. Senate Finance Committee as a David A. Winston Fellow, learning first-hand the process of drafting and developing federal legislation. While earning a joint J.D./M.P.H. degree from the University of Minnesota, she worked at the Cleveland Clinic Foundation and the Minnesota Department of Human Services, offering her insight into the management of legal issues at highly complex organizations. Elizabeth resides in Washington, D.C.